BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 31378673)

  • 1. Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia.
    Menendez-Gonzalez JB; Vukovic M; Abdelfattah A; Saleh L; Almotiri A; Thomas LA; Agirre-Lizaso A; Azevedo A; Menezes AC; Tornillo G; Edkins S; Kong K; Giles P; Anjos-Afonso F; Tonks A; Boyd AS; Kranc KR; Rodrigues NP
    Stem Cell Reports; 2019 Aug; 13(2):291-306. PubMed ID: 31378673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
    Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regnase-1-mediated post-transcriptional regulation is essential for hematopoietic stem and progenitor cell homeostasis.
    Kidoya H; Muramatsu F; Shimamura T; Jia W; Satoh T; Hayashi Y; Naito H; Kunisaki Y; Arai F; Seki M; Suzuki Y; Osawa T; Akira S; Takakura N
    Nat Commun; 2019 Mar; 10(1):1072. PubMed ID: 30842549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
    Nandakumar SK; Johnson K; Throm SL; Pestina TI; Neale G; Persons DA
    Exp Hematol; 2015 Jul; 43(7):565-77.e1-10. PubMed ID: 25907033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax.
    Ye S; Xiong F; He X; Yuan Y; Li D; Ye D; Shi L; Lin Z; Zhao M; Feng S; Zhou B; Weng H; Hong L; Ye H; Gao S
    Theranostics; 2023; 13(1):77-94. PubMed ID: 36593968
    [No Abstract]   [Full Text] [Related]  

  • 6. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
    Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
    Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
    Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
    Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice.
    Li HS; Jin J; Liang X; Matatall KA; Ma Y; Zhang H; Ullrich SE; King KY; Sun SC; Watowich SS
    Eur J Haematol; 2016 Sep; 97(3):261-70. PubMed ID: 26660446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells.
    Thoms JAI; Truong P; Subramanian S; Knezevic K; Harvey G; Huang Y; Seneviratne JA; Carter DR; Joshi S; Skhinas J; Chacon D; Shah A; de Jong I; Beck D; Göttgens B; Larsson J; Wong JWH; Zanini F; Pimanda JE
    Blood; 2021 Oct; 138(16):1441-1455. PubMed ID: 34075404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.
    Park SM; Cho H; Thornton AM; Barlowe TS; Chou T; Chhangawala S; Fairchild L; Taggart J; Chow A; Schurer A; Gruet A; Witkin MD; Kim JH; Shevach EM; Krivtsov A; Armstrong SA; Leslie C; Kharas MG
    Cell Stem Cell; 2019 Jan; 24(1):153-165.e7. PubMed ID: 30472158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis.
    Katayama S; Suzuki M; Yamaoka A; Keleku-Lukwete N; Katsuoka F; Otsuki A; Kure S; Engel JD; Yamamoto M
    Blood; 2017 Aug; 130(7):908-919. PubMed ID: 28630119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the RNA m
    Paris J; Morgan M; Campos J; Spencer GJ; Shmakova A; Ivanova I; Mapperley C; Lawson H; Wotherspoon DA; Sepulveda C; Vukovic M; Allen L; Sarapuu A; Tavosanis A; Guitart AV; Villacreces A; Much C; Choe J; Azar A; van de Lagemaat LN; Vernimmen D; Nehme A; Mazurier F; Somervaille TCP; Gregory RI; O'Carroll D; Kranc KR
    Cell Stem Cell; 2019 Jul; 25(1):137-148.e6. PubMed ID: 31031138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells.
    Kawabata KC; Zong H; Meydan C; Wyman S; Wouters BJ; Sugita M; Goswami S; Albert M; Yip W; Roboz GJ; Chen Z; Delwel R; Carroll M; Mason CE; Melnick A; Guzman ML
    Blood; 2021 Feb; 137(6):812-825. PubMed ID: 32911532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
    Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
    Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
    Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
    Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia.
    Shen C; Chen MT; Zhang XH; Yin XL; Ning HM; Su R; Lin HS; Song L; Wang F; Ma YN; Zhao HL; Yu J; Zhang JW
    PLoS Genet; 2016 Sep; 12(9):e1006259. PubMed ID: 27617961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA2 hypomorphism induces chronic myelomonocytic leukemia in mice.
    Harada N; Hasegawa A; Hirano I; Yamamoto M; Shimizu R
    Cancer Sci; 2019 Apr; 110(4):1183-1193. PubMed ID: 30710465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and molecular characterization of mouse Gata2-independent hematopoietic progenitors.
    Kaimakis P; de Pater E; Eich C; Solaimani Kartalaei P; Kauts ML; Vink CS; van der Linden R; Jaegle M; Yokomizo T; Meijer D; Dzierzak E
    Blood; 2016 Mar; 127(11):1426-37. PubMed ID: 26834239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional memory of cells of origin overrides β-catenin requirement of MLL cancer stem cells.
    Siriboonpiputtana T; Zeisig BB; Zarowiecki M; Fung TK; Mallardo M; Tsai CT; Lau PNI; Hoang QC; Veiga P; Barnes J; Lynn C; Wilson A; Lenhard B; So CWE
    EMBO J; 2017 Nov; 36(21):3139-3155. PubMed ID: 28978671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukemia mutations corrupt but do not abrogate GATA-2 function.
    Katsumura KR; Mehta C; Hewitt KJ; Soukup AA; Fraga de Andrade I; Ranheim EA; Johnson KD; Bresnick EH
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10109-E10118. PubMed ID: 30301799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.